Pursuant to Regulation 30 and 44(3) of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, Kabra Drugs has submitted the voting results of the business transacted at the Extra Ordinary General Meeting (EGM) of the Company held on Saturday, 17th February, 2024 at 04.30 pm and concluded at 5:00 pm at registered office of the company in the prescribed format.
The above information is a part of company’s filings submitted to BSE.